Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults

The Advisory Committee on Immunization Practices (ACIP) recommends recombinant zoster vaccine (RZV) to prevent against herpes zoster (HZ) and related complications in immunocompetent adults ≥50 y and immunocompromised adults ≥19 y. In 2019, a statistical safety signal for Guillain-Barré syndrome (GB...

Descripción completa

Detalles Bibliográficos
Autores principales: Janusz, Cara B., Anderson, Tara C., Leidner, Andrew J., Lee, Grace M., Dooling, Kathleen, Prosser, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Licensed Vaccines – Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897652/
https://www.ncbi.nlm.nih.gov/pubmed/35476029
http://dx.doi.org/10.1080/21645515.2022.2060668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897652/
https://www.ncbi.nlm.nih.gov/pubmed/35476029
http://dx.doi.org/10.1080/21645515.2022.2060668

Ejemplares similares